Green Thumb Industries Inc. (GTBIF)
(Delayed Data from OTC)
$11.06 USD
+0.03 (0.27%)
Updated Aug 8, 2024 09:34 AM ET
2-Buy of 5 2
A Value A Growth A Momentum A VGM
Price, Consensus and EPS Surprise
GTBIF 11.06 +0.03(0.27%)
Will GTBIF be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GTBIF based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GTBIF
Green Thumb Industries Inc. (GTBIF) Q2 Earnings and Revenues Surpass Estimates
Analysts Estimate Verano Holdings Corp. (VRNOF) to Report a Decline in Earnings: What to Look Out for
GTBIF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Green Thumb Industries Inc. (GTBIF) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Agios Pharmaceuticals (AGIO) Surges 6.5%: Is This an Indication of Further Gains?
Wall Street Analysts Believe Green Thumb Industries Inc. (GTBIF) Could Rally 42.3%: Here's is How to Trade
Other News for GTBIF
Wall Street Breakfast Podcast: Household Debt Increases In Q2
Green Thumb Cannabis Q2 Financials Reported Increased Adj. EBITDA Results
Cannabis Boom Or Bust: State Trends Marijuana Investors Can't Afford To Ignore In 2Q24
Analysts Offer Insights on Healthcare Companies: Green Thumb Industries (OtherGTBIF) and Annexon Biosciences (ANNX)
Benchmark Co. Remains a Buy on Green Thumb Industries (GTBIF)